Weekly Recap | Twist Bioscience +3.19%, consensus target below spotWeekly Review·Oct 3, 2026 at 08:40 AMTWST+8.66%
Weekly Recap | Alnylam Pharma -14.16%, one-way sellingWeekly Review·Oct 3, 2026 at 08:28 AMALNY+0.08%
Weekly Recap | RXRX.US +10.16%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:37 AMRXRX+16.02%
Weekly Recap | Roche -4.04%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:34 AMRHHBY+0.50%
Weekly Recap | PURR.US -7.47%, consensus target above spotWeekly Review·Oct 3, 2026 at 07:30 AMPURR+8.66%
Weekly Recap | Kodiak Sciences +191.96%, Zenkuda hits phase 3 goalWeekly Review·Oct 3, 2026 at 07:06 AMKOD-0.68%
Weekly Recap | BioNTech SE this week, CEO trims shares repeatedlyWeekly Review·Oct 3, 2026 at 06:25 AMBNTX+0.76%
Weekly Recap | ABSI.US +13.66%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 06:09 AMABSI+4.16%
U.S. Stocks Open Higher: Nasdaq Up 1.3%, Dow Up 1.1%Wallstreetcn·Mar 31, 2026 at 01:32 PMCNTA0.00%.IXIC+1.05%
Global News You Need to Know Before US Stock Market Open on TuesdayWallstreetcn·Mar 31, 2026 at 12:52 PM300164-1.03%AEM-0.20%
The Nasdaq Biotechnology Index fell by approximately 1.7%. Among the constituent stocks, Regenxbio dropped 17.90%, Altimmune fell 17.15%, Jyong Biotech decreased by 15.95%, Coherus BioSciences declined 11.75%, Relay Therapeutics Inc fell 10.06%, and Maravai Lifesciences dropped 10.00%. Meanwhile, Apellis Pharma rose 5.82%, Kodiak Sciences increased by 6.28%, Alumis went up 6.58%, and Zenas Biopharma gained 7.03%Wallstreetcn·Jan 28, 2026 at 11:57 PMRGNX+4.44%BBH+1.30%
